Lars Petter Jordheim (Lars P Jordheim)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 24

Top Topics

High Resolution Mass Spectrometry

Oxidative Stress

Top Venues

Nucleosides, nucleotides & nucleic acids

International journal of molecular sciences

Purinergic signalling

This page only lists publications with an associated author ORCID identifier.

Publications

Jérôme Guitton, Floriane Gavotto, Emeline Cros-Perrial, Lars Petter Jordheim, Christelle Machon
A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method. International journal of molecular sciences 24 (4) (2023)
Lars Petter Jordheim
PARP Inhibitors and Proteins Interacting with SLX4. Cancers 15 (3) (2023)
Jérôme Guitton, Floriane Gavotto, Emeline Cros-Perrial, Lars Petter Jordheim, Christelle Machon
A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method. International journal of molecular sciences 24 (4) (2023)
Jérôme Guitton, Floriane Gavotto, Emeline Cros-Perrial, Lars Petter Jordheim, Christelle Machon
A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method. International journal of molecular sciences 24 (4) (2023)
Lars Petter Jordheim
PARP Inhibitors and Proteins Interacting with SLX4. Cancers 15 (3) (2023)
Jérôme Guitton, Floriane Gavotto, Emeline Cros-Perrial, Lars Petter Jordheim, Christelle Machon
A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method. International journal of molecular sciences 24 (4) (2023)
Lars Petter Jordheim, Caius G Radu, Godefridus J Peters
Looking for the unexpected in purine and pyrimidine metabolism. Nucleosides, nucleotides & nucleic acids (2023)
Lars Petter Jordheim
Clinical use of biomarkers in the field of cytotoxic nucleoside analogues. Nucleosides, nucleotides & nucleic acids (2023)
Morgane Denis, Chloé Grasselly, Pierre-Antoine Choffour, Anne Wierinckx, Doriane Mathé, Kamel Chettab, Anne Tourette, Nolan Talhi, Aurore Bourguignon, Fabian Birzele, Elsa Kress, Lars Petter Jordheim, Christiane Neumann, Eva-Laure Matera, Charles Dumontet
In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies. Cancer immunology research 10 (8) (2022)
Olivier Harou, Emeline Cros-Perrial, Eudeline Alix, Evelyne Callet-Bauchu, Charlotte Bertheau, Charles Dumontet, Mojgan Devouassoux-Shisheboran, Lars Petter Jordheim
Variability in CD39 and CD73 protein levels in uveal melanoma patients. Nucleosides, nucleotides & nucleic acids 41 (11) (2022)
Carine Domenech, Adriana Plesa, Anne Tourette, Yves Bertrand, Arthur Dony, Charles Dumontet, Emeline Cros-Perrial, Lars Petter Jordheim
Prognostic impact of cN-III mRNA expression on overall survival and drug sensitivity in pediatric leukemia. Leukemia & lymphoma (2021)
Octavia Cadassou, Prescillia Forey, Christelle Machon, Edoardo Petrotto, Kamel Chettab, Maria Grazia Tozzi, Jérôme Guitton, Charles Dumontet, Emeline Cros-Perrial, Lars Petter Jordheim
Transcriptional and Metabolic Investigation in 5'-Nucleotidase Deficient Cancer Cell Lines. Cells 10 (11) (2021)
Gloria Ciniero, Ahmed H Elmenoufy, Francesco Gentile, Michael Weinfeld, Marco A Deriu, Frederick G West, Jack A Tuszynski, Charles Dumontet, Emeline Cros-Perrial, Lars Petter Jordheim
Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1-XPF-mediated DNA repair. Cancer chemotherapy and pharmacology 87 (2) (2021)
Lars Petter Jordheim, Godefridus J Peters
New insights in research on purine and pyrimidine metabolism. Nucleosides, nucleotides & nucleic acids (2021)
Rossana Pesi, Simone Allegrini, Mercedes Garcia-Gil, Lucia Piazza, Roberta Moschini, Lars Petter Jordheim, Marcella Camici, Maria Grazia Tozzi
Cytosolic 5'-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway. International journal of molecular sciences 22 (13) (2021)
Lars Petter Jordheim
The amazing cN-II, the enzyme that keeps us busy. Nucleosides, nucleotides & nucleic acids (2021)
Rossana Pesi, Simone Allegrini, Francesco Balestri, Mercedes Garcia-Gil, Federico Cividini, Laura Colombaioni, Lars Petter Jordheim, Marcella Camici, Maria Grazia Tozzi
Cytosolic 5'-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator. Cells 10 (1) (2021)
Ivana Spasevska, Eva Laure Matera, Kamel Chettab, Jade Ville, Marie Potier-Cartereau, Lars Petter Jordheim, Catherine Thieblemont, Denis Sahin, Christiane Neumann, Charles Dumontet
Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction. Molecular cancer therapeutics 19 (11) (2020)
Regina Strakhova, Octavia Cadassou, Emeline Cros-Perrial, Lars Petter Jordheim
Regulation of tumor infiltrated innate immune cells by adenosine. Purinergic signalling 16 (3) (2020)
Octavia Cadassou, Muhammad-Zawwad Raza, Christelle Machon, Laura Gudefin, Célia Armanet, Kamel Chettab, Jérôme Guitton, Maria Grazia Tozzi, Charles Dumontet, Emeline Cros-Perrial, Lars Petter Jordheim
Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation. Cellular oncology (Dordrecht) 44 (1) (2020)
Tormod Karlsen Bjånes, Lars Petter Jordheim, Jan Schjøtt, Tina Kamceva, Emeline Cros-Perrial, Anika Langer, Gorka Ruiz de Garibay, Spiros Kotopoulis, Emmet McCormack, Bettina Riedel
Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines. Drug metabolism and disposition: the biological fate of chemicals 48 (3) (2019)
Rayane Ghoteimi, Van Tai Nguyen, Rahila Rahimova, Felix Grosjean, Emeline Cros-Perrial, Jean-Pierre Uttaro, Christophe Mathé, Laurent Chaloin, Lars Petter Jordheim, Suzanne Peyrottes
Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73. ChemMedChem 14 (15) (2019)
Lars Petter Jordheim
Expanding the clinical relevance of the 5'-nucleotidase cN-II/NT5C2. Purinergic signalling 14 (4) (2018)
Muhammad-Zawwad Raza, Simone Allegrini, Charles Dumontet, Lars Petter Jordheim
Functions of the multi-interacting protein KIDINS220/ARMS in cancer and other pathologies. Genes, chromosomes & cancer 57 (3) (2017)